311 related articles for article (PubMed ID: 28379297)
1. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
[TBL] [Abstract][Full Text] [Related]
2. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
3. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
[TBL] [Abstract][Full Text] [Related]
4. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
5. Pyrroline-5-Carboxylate Reductase 1 Accelerates the Migration and Invasion of Nonsmall Cell Lung Cancer
Sang S; Zhang C; Shan J
Cancer Biother Radiopharm; 2019 Aug; 34(6):380-387. PubMed ID: 30916574
[No Abstract] [Full Text] [Related]
6.
Christensen EM; Bogner AN; Vandekeere A; Tam GS; Patel SM; Becker DF; Fendt SM; Tanner JJ
J Biol Chem; 2020 Dec; 295(52):18316-18327. PubMed ID: 33109600
[TBL] [Abstract][Full Text] [Related]
7. SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism.
Chen S; Yang X; Yu M; Wang Z; Liu B; Liu M; Liu L; Ren M; Qi H; Zou J; Vucenik I; Zhu WG; Luo J
Neoplasia; 2019 Jul; 21(7):665-675. PubMed ID: 31108370
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.
Zhang H; Liu X; Warden CD; Huang Y; Loera S; Xue L; Zhang S; Chu P; Zheng S; Yen Y
BMC Cancer; 2014 Sep; 14():664. PubMed ID: 25213022
[TBL] [Abstract][Full Text] [Related]
9. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.
Bogner AN; Stiers KM; Tanner JJ
Amino Acids; 2021 Dec; 53(12):1817-1834. PubMed ID: 34003320
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
11. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W
J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma.
Xu Y; Zuo W; Wang X; Zhang Q; Gan X; Tan N; Jia W; Liu J; Li Z; Zhou B; Zhao D; Xie Z; Tan Y; Zheng S; Liu C; Li H; Chen Z; Yang X; Huang Z
Int J Biol Sci; 2021; 17(9):2223-2239. PubMed ID: 34239351
[TBL] [Abstract][Full Text] [Related]
13. Increased PYCR1 mRNA predicts poor prognosis in kidney adenocarcinoma: A study based on TCGA database.
Zhang T; Liu Y; Liu W; Li Q; Hou W; Huang Y; Lv P; Meng L; Li Y; Jia Y; Liu X; Zuo Z
Medicine (Baltimore); 2021 Sep; 100(38):e27145. PubMed ID: 34559102
[TBL] [Abstract][Full Text] [Related]
14. Proteomic patterns associated with response to breast cancer neoadjuvant treatment.
Shenoy A; Belugali Nataraj N; Perry G; Loayza Puch F; Nagel R; Marin I; Balint N; Bossel N; Pavlovsky A; Barshack I; Kaufman B; Agami R; Yarden Y; Dadiani M; Geiger T
Mol Syst Biol; 2020 Sep; 16(9):e9443. PubMed ID: 32960509
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer.
Zeng T; Zhu L; Liao M; Zhuo W; Yang S; Wu W; Wang D
Med Oncol; 2017 Feb; 34(2):27. PubMed ID: 28078560
[TBL] [Abstract][Full Text] [Related]
16. Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.
Oudaert I; Satilmis H; Vlummens P; De Brouwer W; Maes A; Hose D; De Bruyne E; Ghesquière B; Vanderkerken K; De Veirman K; Menu E
J Exp Clin Cancer Res; 2022 Feb; 41(1):45. PubMed ID: 35105345
[TBL] [Abstract][Full Text] [Related]
17. DJ-1 cooperates with PYCR1 in cell protection against oxidative stress.
Yasuda T; Kaji Y; Agatsuma T; Niki T; Arisawa M; Shuto S; Ariga H; Iguchi-Ariga SM
Biochem Biophys Res Commun; 2013 Jun; 436(2):289-94. PubMed ID: 23743200
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of PYCR1 expression in renal cell carcinoma.
Weijin F; Zhibin X; Shengfeng Z; Xiaoli Y; Qijian D; Jiayi L; Qiumei L; Yilong C; Hua M; Deyun L; Jiwen C
Medicine (Baltimore); 2019 Jul; 98(28):e16384. PubMed ID: 31305441
[TBL] [Abstract][Full Text] [Related]
19. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
[TBL] [Abstract][Full Text] [Related]
20. MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.
Craze ML; Cheung H; Jewa N; Coimbra NDM; Soria D; El-Ansari R; Aleskandarany MA; Wai Cheng K; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Br J Cancer; 2018 Jan; 118(2):258-265. PubMed ID: 29169183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
